Adipotide 5mg
GrowthAdipotide (FTPP, Fat-Targeted Proapoptotic Peptide) was developed at MD Anderson Cancer Center and the Barshop Institute for Longevity and Aging Studies. Rather than acting on hormones or appetite, it's designed to trigger apoptosis specifically in the blood vessels supplying white adipose tissue — starving fat cells of blood flow rather than signaling the body to burn them.
Is Adipotide FDA-approved?+
No. It has never been approved by the FDA or any other regulatory body and is sold strictly for research use.
What evidence exists for Adipotide?+
The most notable data is a study in obese rhesus monkeys, where treated animals lost weight and showed improved insulin sensitivity within a month, with imaging confirming reduced white adipose tissue. Human trial data is not established.
How is it different from GLP-1 peptides like Semaglutide or Tirzepatide?+
Those work through appetite and metabolic hormone receptors. Adipotide's proposed mechanism is structural — collapsing the microvasculature that feeds fat tissue, causing localized cell death rather than a systemic metabolic shift.
Need something specific, or placing a wholesale order? Message us on Telegram — fastest way to reach us.